Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Long-Term Debt Issuances (2019)

Historic Long-Term Debt Issuances for Avidity Biosciences (RNA) over the last 1 years, with Q3 2019 value amounting to -$7000.0.

  • Avidity Biosciences' Long-Term Debt Issuances changed N/A to -$7000.0 in Q3 2019 from the same period last year, while for Dec 2020 it was -$7000.0, marking a year-over-year change of. This contributed to the annual value of $19.5 million for FY2019, which is 55097.05% up from last year.
  • As of Q3 2019, Avidity Biosciences' Long-Term Debt Issuances stood at -$7000.0.
  • Avidity Biosciences' Long-Term Debt Issuances' 5-year high stood at -$7000.0 during Q3 2019, with a 5-year trough of -$7000.0 in Q3 2019.